These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 16299539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
    Liu TC, Galanis E, Kirn D.
    Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG, Horvath JC.
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [Abstract] [Full Text] [Related]

  • 5. Advances in oncolytic viral therapy.
    Woo Y, Adusumilli PS, Fong Y.
    Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
    [Abstract] [Full Text] [Related]

  • 6. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y, Todo T.
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M, Hermiston TW.
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [Abstract] [Full Text] [Related]

  • 9. Gene therapy progress and prospects cancer: oncolytic viruses.
    Liu TC, Kirn D.
    Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
    [Abstract] [Full Text] [Related]

  • 10. Future prospects for oncolytic therapy.
    McCormick F.
    Oncogene; 2005 Nov 21; 24(52):7817-9. PubMed ID: 16299540
    [Abstract] [Full Text] [Related]

  • 11. [Viral therapy of cancer].
    Suzuki K, Curiel DT.
    Rev Invest Clin; 2001 Nov 21; 53(4):346-56. PubMed ID: 11599483
    [Abstract] [Full Text] [Related]

  • 12. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S, Guo ZS, O'Malley ME, Yin X, Zeh HJ, Bartlett DL.
    Gene Ther; 2007 Apr 21; 14(8):638-47. PubMed ID: 17268533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncolytic virus therapy for prostate cancer.
    Fukuhara H, Homma Y, Todo T.
    Int J Urol; 2010 Jan 21; 17(1):20-30. PubMed ID: 19832925
    [Abstract] [Full Text] [Related]

  • 18. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM, Bell JC, Vähä-Koskela MJ.
    Cytokine Growth Factor Rev; 2010 Jan 21; 21(2-3):177-83. PubMed ID: 20219409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE, Nettelbeck DM.
    Adv Drug Deliv Rev; 2009 Jul 02; 61(7-8):554-71. PubMed ID: 19394376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.